🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study \[contRAst 1 (201790: NCT03980483)\] is a phase 3, randomized, m...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-16
Trial ID
NCT03980483
Treatments Being Tested
This study is designed to explore the activity of granulocyte-macrophage co...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-15
Trial ID
NCT02799472
Treatments Being Tested
This is a randomized, Phase IIa, multicentre, double-blind, placebo-control...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-17
Trial ID
NCT02683785
Treatments Being Tested
This study (contRAst 3 \[202018: NCT04134728\]) is a Phase 3, randomized, m...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-31
Trial ID
NCT04134728
Treatments Being Tested
This study \[contRAst 2 (201791: NCT03970837)\] is a phase 3, randomized, m...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-06-05
Trial ID
NCT03970837
Treatments Being Tested
OSCAR (Otilimab in Severe COVID-19 Related Disease) is a multi-center, doub...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-05-28
Trial ID
NCT04376684
Treatments Being Tested
RA is a chronic, systemic inflammatory autoimmune disease which requires tr...
Status
Terminated
Location
GSK Investigational Site
Start Date
2020-05-12
Trial ID
NCT04333147
Treatments Being Tested
This is a randomised, Phase IIb, dose-adaptive, multicentre, double-blind, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-07-23
Trial ID
NCT02504671
Treatments Being Tested